Cargando…
Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents
The gut hormone glucagon-like peptide (GLP)-1 and its analogues represent a new generation of anti-diabetic drugs, which have also demonstrated propensity to modulate host lipid metabolism. Despite this, drugs of this nature are currently limited to intramuscular administration routes due to intesti...
Autores principales: | Ryan, Paul M., Patterson, Elaine, Kent, Robert M., Stack, Helena, O’Connor, Paula M., Murphy, Kiera, Peterson, Veronica L., Mandal, Rupasri, Wishart, David S., Dinan, Timothy G., Cryan, John F., Seeley, Randy J., Stanton, Catherine, Ross, R. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648875/ https://www.ncbi.nlm.nih.gov/pubmed/29051554 http://dx.doi.org/10.1038/s41598-017-14010-x |
Ejemplares similares
-
Author Correction: Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents
por: Ryan, Paul M., et al.
Publicado: (2020) -
Mood by microbe: towards clinical translation
por: Dinan, Timothy G., et al.
Publicado: (2016) -
Immune modulation of the brain-gut-microbe axis
por: El Aidy, Sahar, et al.
Publicado: (2014) -
Brain–Gut–Microbe Communication in Health and Disease
por: Grenham, Sue, et al.
Publicado: (2011) -
Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling
por: Scriven, Mary, et al.
Publicado: (2018)